Preclinical Studies Demonstrate Durable Protection Against SARS-CoV-2 Variants, Including Omicron XBB.1.5, Driven by T-Cell ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

Ascletis Pharma Inc. announced that it will present poster presentations on its investigational drugs, ASC30 and ASC47, at the 85th Scientific Sessions of the American Diabetes As ...

With 12 symposia as well as several hundred research presentations, the 2025 PSA Annual Meeting will bring together poultry ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing a poster ...

The 39th annual meeting of the Associated Professional Sleep Societies (APSS) will present the latest clinical data and ...

Sobi® (STO: SOBI) will have a strong scientific presence at this year's ERA congress in Vienna (4-7 June) with a total of eight presentations: six oral presentations and two posters. We are proud that ...